We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sample Management System Is Combined with Lab Analyses

By Labmedica staff writers
Posted on 16 Jul 2008
A sample management system has been developed that can be combined with analysis systems for immunology and clinical chemistry.

VersaCell Combo, developed by Siemens Healthcare (Erlangen, Germany), is a cost-effective solution for the combination of immunology diagnostics and clinical chemistry. More...
The sample management system combines Siemens' Immulite 2000 or Immulite 2500 analysis systems with the Advia 1800, the analysis system for clinical chemistry. The throughput of the individual modules is identical with that of the stand-alone systems. If one of the modules fails, the other system can continue with sample processing without interruption of operations.

The system accommodates up to 200 sample tubes, identifies the tests and the patient, and feeds the relevant samples to the corresponding analysis system. Technologists do not have to manually sort the tubes or forward them from one system to the next if samples have to be tested for various analytes. VersaCell Combo enables efficient processing and allows the automation of processes in the lab.

The requested assays are detected using patient barcodes on the tubes and direct communication with the lab information system (LIS) and the samples are automatically fed to the correct module. A robot arm continuously feeds and discharges the samples without interrupting test processing in the two analysis systems. Emergency samples can be analyzed quickly and without delay, by directly applying up to 79 different methods. VersaCell Combo monitors the status of the connected analysis systems, as well as the on-board reagent supply and generates an alarm signal if reagents need to be replaced.

The system was designed for large and medium-sized labs. A comprehensive test menu combines more than 180 assays for routine, protein, medication, and drug analysis in clinical chemistry with the spectrum of immunology diagnostics including the fields of fertility, thyroid gland, and tumor markers.


Related Links:
Siemens

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.